136 related articles for article (PubMed ID: 4823395)
21. Oral contraceptives, lipoproteins, and atherosclerosis.
Adams MR; Clarkson TB; Shively CA; Parks JS; Kaplan JR
Am J Obstet Gynecol; 1990 Oct; 163(4 Pt 2):1388-93. PubMed ID: 2220963
[TBL] [Abstract][Full Text] [Related]
22. Comparison of metabolic and clinical effects of four oral contraceptive formulations and a contraceptive vaginal ring.
Roy S; Mishell DR; Gray G; Dozono-Takano R; Brenner PF; Eide I; de Quattro V; Shaw ST
Am J Obstet Gynecol; 1980 Apr; 136(7):920-31. PubMed ID: 6767404
[TBL] [Abstract][Full Text] [Related]
23. Carbohydrate and lipid studies during six months' treatment with megestrol acetate. Measurements of blood glucose, insulin, growth hormone, and triglycerides.
Spellacy WN; Newton RE; Buhi WC; Birk SA
Am J Obstet Gynecol; 1973 Aug; 116(8):1074-8. PubMed ID: 4721135
[TBL] [Abstract][Full Text] [Related]
24. The effect of a desogestrel-containing oral contraceptive on glucose tolerance and leptin concentrations in hyperandrogenic women.
Nader S; Riad-Gabriel MG; Saad MF
J Clin Endocrinol Metab; 1997 Sep; 82(9):3074-7. PubMed ID: 9284746
[TBL] [Abstract][Full Text] [Related]
25. Studies on the effects of oestradiol, progesterone and some steroidal contraceptives on the adrenal cortex of albino rats.
Zaki K; Sami GE; Wassef SA; Nour H; Hassan AA
Egypt Popul Fam Plann Rev; 1973 Jun; 6(1):33-50. PubMed ID: 12257875
[TBL] [Abstract][Full Text] [Related]
26. [Insulin and proinsulin secretion under contraceptive steroid administration (author's transl)].
Hausmann L; Goebel KM; Klähn D; Kaffarnik H
Klin Wochenschr; 1975 Sep; 53(18):853-60. PubMed ID: 1165627
[TBL] [Abstract][Full Text] [Related]
27. Blood glucose and plasma insulin levels with ethynodiol diacetate oral contraceptive.
Goldman JA; Eckerling B; Zukerman Z; Mannheimer S
J Obstet Gynaecol Br Commonw; 1971 Mar; 78(3):255-60. PubMed ID: 5558841
[No Abstract] [Full Text] [Related]
28. Effects of ethinyl estradiol combined with desogestrel and cyproterone acetate on glucose tolerance and insulin response to an oral glucose load: a one-year randomized, prospective, comparative trial.
Jandrain BJ; Humblet DM; Jaminet CB; Scheen AJ; Gaspard UJ; Lefebvre PJ
Am J Obstet Gynecol; 1990 Jul; 163(1 Pt 2):378-81. PubMed ID: 2142578
[TBL] [Abstract][Full Text] [Related]
29. The effects of an oral contraceptive on plasma growth hormone and glucose tolerance in two strains of rats.
Arnold TS; Thye FW
Am J Clin Nutr; 1977 Mar; 30(3):381-7. PubMed ID: 842489
[TBL] [Abstract][Full Text] [Related]
30. Effects of oral contraceptive agents on copper and zinc balance in young women.
Crews MG; Taper LJ; Ritchey SJ
Am J Clin Nutr; 1980 Sep; 33(9):1940-5. PubMed ID: 7416062
[TBL] [Abstract][Full Text] [Related]
31. Glucose and insulin levels after six months of treatment with a triphasic oral contraceptive containing ethinyl estradiol and norethindrone.
Spellacy WN; Ellingson AB; Tsibris JC
J Reprod Med; 1989 Aug; 34(8):540-2. PubMed ID: 2681750
[TBL] [Abstract][Full Text] [Related]
32. An open assessment of a new low dose oestrogen combined oral contraceptive.
Hughes I
J Int Med Res; 1978; 6(1):41-5. PubMed ID: 627304
[TBL] [Abstract][Full Text] [Related]
33. Effect of duration of low-dose oral contraceptive administration on carbohydrate metabolism.
Wynn V
Am J Obstet Gynecol; 1982 Mar; 142(6 Pt 2):739-46. PubMed ID: 6801979
[TBL] [Abstract][Full Text] [Related]
34. Effects of a new oral contraceptive containing an antimineralocorticoid progestogen, drospirenone, on the renin-aldosterone system, body weight, blood pressure, glucose tolerance, and lipid metabolism.
Oelkers W; Foidart JM; Dombrovicz N; Welter A; Heithecker R
J Clin Endocrinol Metab; 1995 Jun; 80(6):1816-21. PubMed ID: 7775629
[TBL] [Abstract][Full Text] [Related]
35. Oral contraceptives: effects on carbohydrate metabolism, insulin like activity and histology of the pancreas.
Kulkarni HJ; Gaitonde BB; Bandisode MS
Horm Metab Res; 1980 Oct; 12(10):497-504. PubMed ID: 7002754
[TBL] [Abstract][Full Text] [Related]
36. Serum levels of d-norgestrel, luteinizing hormone, follicle-stimulating hormone, estradiol, and progesterone in women during and following ingestion of combination oral contraceptives containing dl-norgestrel.
Brenner PF; Mishell DR; Stanczyk FZ; Goebelsmann U
Am J Obstet Gynecol; 1977 Sep; 129(2):133-40. PubMed ID: 900174
[TBL] [Abstract][Full Text] [Related]
37. Carbohydrate metabolism prospectively studied in women using a low-estrogen oral contraceptive for six months.
Spellacy WN; Buhi WC; Birk SA
Contraception; 1979 Aug; 20(2):137-48. PubMed ID: 487817
[TBL] [Abstract][Full Text] [Related]
38. New progestogens in oral contraceptives.
Runnebaum B; Rabe T
Am J Obstet Gynecol; 1987 Oct; 157(4 Pt 2):1059-63. PubMed ID: 2960242
[TBL] [Abstract][Full Text] [Related]
39. Experience with ethynodiol diacetate and mestranol as an oral contraceptive.
Gidwani GP; Purandare BN
J Obstet Gynaecol India; 1968 Apr; 18(2):287-93. PubMed ID: 12331821
[TBL] [Abstract][Full Text] [Related]
40. The effects of oral contraceptives on glucose tolerance.
Boshell BR; Roddam RF; McAdams GL; Fox OJ
J Reprod Fertil Suppl; 1968 Dec; 5():Suppl 5:77-88. PubMed ID: 5288232
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
